A phase 2 study of the decision of surgical adjustment time based on IDRF (Image Defined Risk Factors), and chemotherapy that gradually improve strength for intermediate risk neuroblastoma
Phase 2
Recruiting
- Conditions
- intermediate risk neuroblastomas
- Registration Number
- JPRN-UMIN000004700
- Lead Sponsor
- Japan Neuroblastoma Study Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 73
Inclusion Criteria
Not provided
Exclusion Criteria
(1)duplicate cancer (2)history of pregnancy or lactation (3) Patients complicated the mental disease or psychotic condition and were judged that can not participate in the study. (4) Patients whose participation in the study is judged to be inappropriate by the attending doctor
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method